Question explored with the scientific record
FND lifelong condition
The short version: FND is often a lifelong condition, but the evidence on long-term outcomes is thin and mostly from small, old studies.
The best long-term data comes from a 2003 study that followed 42 patients with unilateral functional weakness or sensory disturbance for a median of 12.5 years [1]. The results are sobering. At follow-up, 69% still reported weakness, 48% numbness, 67% sleep difficulties, and 58% fatigue. About 29% had taken medical retirement. Only 1 of 47 patients (2%) was later found to have been misdiagnosed, which means the diagnosis held up over time for nearly everyone [1]. This study is small and from a single center, but it is the only one that tracks FND over a decade.
A 2020 systematic review on FND and multiple sclerosis found that misdiagnosis rates in FND are roughly 1-4%, with about 10% of those misdiagnoses being MS [3]. That means about 0.1-0.4% of people diagnosed with FND actually have MS. The same review found that in studies of patients misdiagnosed with MS, functional or psychiatric disorders accounted for 5-51% of the misdiagnoses [3]. So the two conditions can be mistaken for each other, but true misdiagnosis of FND is uncommon.
A 2020 case report shows that FND can be revised to a progressive neurological disease like progressive supranuclear palsy (PSP) when symptoms evolve [2]. That patient was initially diagnosed with FND after 3 years of symptoms, but over time developed clear signs of PSP including ophthalmoplegia and falls. This is a reminder that FND is a diagnosis that should be revisited if symptoms change or worsen in a pattern that suggests an underlying neurodegenerative process.
For treatment, a 2020 narrative review describes a stepped care model: education after diagnosis, then brief psychotherapeutic or rehabilitation interventions, then specialized multidisciplinary therapy for those who do not improve [4]. A specialized 5-day physical therapy protocol for functional movement disorder showed 72% symptom improvement at 6 months versus 18% in controls [4]. A 3-week inpatient rehabilitation program for gait disorder improved walking ability and functional independence, with effects sustained at 1 year [4]. These are the best treatment data available, but they come from small, uncontrolled studies.
| Outcome | Rate at 12.5 years [1] |
|---|---|
| Still have weakness | 69% |
| Still have numbness | 48% |
| Sleep difficulties | 67% |
| Fatigue | 58% |
| Medical retirement | 29% |
| Misdiagnosis | 2% |
My call: FND is a real diagnosis that persists for most people over a decade. The evidence is weak on what predicts recovery and what treatments work best long-term. The condition can be lifelong, but some people improve with specialized rehabilitation. Confidence: moderate for the persistence data, low for treatment effectiveness.
Sources used 4
-
The 12 year prognosis of unilateral functional weakness and sensory disturbance
This study investigates the long-term outcomes of patients diagnosed with unilateral functional weakness or sensory disturbance, revealing that a significant majority remain symptomatic and disabled many years after their initial diagnosis.
DOI: 10.1136/jnnp.74.5.591 -
Revising a diagnosis of functional neurological disorder—a case report
A case report of a 62-year-old woman initially diagnosed with functional neurological disorder (FND) whose diagnosis was revised to progressive supranuclear palsy (PSP) after serial clinical assessments and targeted neuroimaging, highlighting diagnostic shadowing and the value o…
DOI: 10.1093/omcr/omaa073 -
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap
MS and FND are not infrequently mistaken for one another, and comorbidity may be more common than acknowledged.
DOI: 10.1007/s00415-021-10436-6 -
Treatment of functional neurological disorder: current state, future directions, and a research agenda
An evidence-informed narrative review that summarizes current approaches to treating functional neurological disorder (FND), contrasts treatment modalities for PNES and FMD, and lays out a comprehensive, multidisciplinary research agenda to improve treatment delivery, trial desi…
DOI: 10.1017/S1092852920002138